Inozyme Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 5.67 M | $29.67 M | -0.96% | 8.97% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2024 | 4.49 M | $23.51 M | 0.00% | 7.10% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 4.28 M | $22.39 B | 0.00% | 6.76% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 4.13 M | $21.62 M | 5.04% | 6.53% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 3.80 M | $19.89 M | 2.83% | 6.01% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.49 M | $18.26 M | 100.00% | 5.52% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 3.26 M | $17.05 M | -2.73% | 5.15% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 2.82 M | $14.76 M | -1.19% | 4.46% |
| VANGUARD GROUP INC | 11/13/2024 | 2.62 M | $13.73 M | -0.19% | 4.15% |
| FMR LLC | 11/13/2024 | 2.48 M | $12.96 M | 0.05% | 3.92% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 2.44 M | $12.75 M | 0.00% | 3.85% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.74 M | $9.12 M | -2.43% | 2.76% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 1.56 M | $8.17 M | 0.00% | 2.47% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.37 M | $7.16 M | 20.04% | 2.16% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 1.19 M | $6.23 M | -18.57% | 1.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.17 M | $6.13 M | 1.69% | 1.85% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 1.12 M | $5.86 M | 0.00% | 1.77% |
| STATE STREET CORP | 11/14/2024 | 1.05 M | $5.49 M | 5.04% | 1.66% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.00 M | $5.25 M | 0.24% | 1.59% |
| KNOTT DAVID M JR | 11/13/2024 | 564,549 | $2.95 M | 0.00% | 0.89% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 447,317 | $2.34 M | 23.61% | 0.71% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 446,152 | $2.33 M | 17.39% | 0.71% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 260,719 | $1.36 M | 11.91% | 0.41% |
| UBS OCONNOR LLC | 11/14/2024 | 226,232 | $1.18 M | 10.24% | 0.36% |
| OVERBROOK MANAGEMENT CORP | 11/08/2024 | 219,326 | $1.15 M | 0.00% | 0.35% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 202,729 | $1.06 M | 26.01% | 0.32% |
| PALE FIRE CAPITAL SE | 11/12/2024 | 188,537 | $986,049 | 384.66% | 0.30% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 164,800 | $861,904 | -12.27% | 0.26% |
| MORGAN STANLEY | 11/14/2024 | 158,846 | $830,763 | 101.33% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 155,696 | $814,288 | -18.44% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 143,158 | $748,716 | 0.00% | 0.23% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 121,614 | $636,041 | -13.15% | 0.19% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 78,400 | $410,032 | 100.00% | 0.12% |
| RHUMBLINE ADVISERS | 11/12/2024 | 76,817 | $401,740 | -0.24% | 0.12% |
| BARCLAYS PLC | 11/19/2024 | 76,730 | $401,000 | 261.37% | 0.12% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 71,086 | $371,780 | 24.49% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2024 | 49,560 | $259,199 | 91.39% | 0.08% |
| JANE STREET GROUP, LLC | 11/15/2024 | 49,460 | $258,675 | 7.48% | 0.08% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 48,056 | $251,000 | -12.92% | 0.08% |
| ALPS ADVISORS INC | 11/12/2024 | 44,562 | $233,059 | -7.67% | 0.07% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 35,402 | $185,000 | -13.51% | 0.06% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 34,990 | $182,998 | 7.17% | 0.06% |
| JPMORGAN CHASE & CO | 12/26/2024 | 28,928 | $151,293 | 31.03% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 28,364 | $148,344 | 16.22% | 0.04% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 28,093 | $146,926 | 100.00% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 27,949 | $146,173 | 0.00% | 0.04% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 27,641 | $144,562 | -0.61% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 25,764 | $134,745 | 63.34% | 0.04% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 24,534 | $128,313 | 8.02% | 0.04% |
| BAILARD, INC. | 10/30/2024 | 24,300 | $127,089 | 0.00% | 0.04% |
Inozyme Pharma, Inc.institutional Ownership - FAQ's
During the previous two years, 101 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:
GAMMA Investing LLC: 0
ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.67 M
Pivotal bioVenture Partners Investment Advisor LLC: 4.49 M
Sofinnova Investments, Inc.: 4.28 M
EVENTIDE ASSET MANAGEMENT, LLC: 4.13 M
Rock Springs Capital Management LP: 3.8 M
86.27% of Inozyme Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 58.94 M shares in the last 24 months. This purchase volume represents approximately $88.41 M in transactions.